GEHC Q4 2025 earnings call recap: revenue, record backlog, 2026 guidance, Intelerad deal, Flyrcado ramp, tariffs & China risks—read key takeaways.

GE HealthCare (Nasdaq: GEHC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast.

GE HealthCare beat earnings and revenue estimates, saw strong growth in imaging and drug units, managed tariff costs and ...

GE HealthCare posted full-year growth of 4.8% in 2025, including 7.1% revenue growth in its fourth quarter, beating analyst ...

GE HealthCare reported fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was looking for ...

This collection of health news highlights includes GE HealthCare predicting a profit surge due to a high demand for diagnostic devices, Nestle expanding a recall due to toxin levels, advisories on ...

GE HealthCare (GEHC) stock gains as the company beats forecsts with its Q4 earnings and revenue and issues 2026 outlook also exceeding the consensus. Read more here.

GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust demand for its diagnostic ...

GE HealthCare Technologies said profit fell in the fourth quarter, despite higher revenue, as the company continues to operate in what Chief Executive Peter Arduini called a dynamic macroeconomic ...

The earnings results for GE HealthCare Techs (NASDAQ: GEHC) for Q4 were made public on Wednesday, February 4, 2026 at 06:20 ...

CHICAGO (AP) — CHICAGO (AP) — GE HealthCare Technologies Inc. (GEHC) on Wednesday reported fourth-quarter earnings of $589 ...